New Method for Synthesizing Tetrasubstituted Dehydroamino Acids ID: 2014-015

An efficient and stereoselective method for transforming alpha, beta-unsaturated esters into E- and Z-dehydroisoleucine to improve peptide drug effectiveness.

Technology Overview

This technology presents a novel method for synthesizing tetrasubstituted dehydroamino acids, specifically focusing on E- and Z-dehydroisoleucine. Developed by researchers at Brigham Young University, this method is characterized by its efficiency and ability to selectively produce desired isomers. The process enhances the rigidity and stability of peptides, aiming to improve their utility as drugs by increasing their binding affinity to biological targets and resistance to enzymatic degradation.

Key Advantages

• Efficient and stereoselective synthesis process
• Improves peptide rigidity and stability
• Enhances peptide binding to biological targets
• Increases resistance to enzymatic degradation
• Simplifies synthesis compared to existing methods, avoiding the need for protective groups

Problems Addressed

• Complexity and inefficiency in current dehydroamino acid synthesis
• Limited stability and rigidity of peptides for drug development
• High degradation rates of peptide-based drugs in biological systems

Market Applications

• Pharmaceuticals: Development of more effective peptide-based drugs
• Biotechnology: Research tools for studying protein interactions and functions
• Drug Design: Custom synthesis of stable, high-affinity peptides for targeted therapies

Additional Information

Technology ID: 2014-015
Sell Sheet: Download the Sell Sheet here
Market Analysis: Contact us for a more in-depth market report
Date Published: 06 May, 2025